Primary and secondary care service use and costs associated with frailty in an ageing population: longitudinal analysis of an English primary care cohort of adults aged 50 and over, 2006-2017
- PMID: 38337044
- PMCID: PMC10857897
- DOI: 10.1093/ageing/afae010
Primary and secondary care service use and costs associated with frailty in an ageing population: longitudinal analysis of an English primary care cohort of adults aged 50 and over, 2006-2017
Abstract
Background: Frailty becomes more prevalent and healthcare needs increase with age. Information on the impact of frailty on population level use of health services and associated costs is needed to plan for ageing populations.
Aim: To describe primary and secondary care service use and associated costs by electronic Frailty Index (eFI) category.
Design and setting: Retrospective cohort using electronic health records. Participants aged ≥50 registered in primary care practices contributing to the Oxford Royal College of General Practitioners Research and Surveillance Centre, 2006-2017.
Methods: Primary and secondary care use (totals and means) were stratified by eFI category and age group. Standardised 2017 costs were used to calculate primary, secondary and overall costs. Generalised linear models explored associations between frailty, sociodemographic characteristics. Adjusted mean costs and cost ratios were produced.
Results: Individual mean annual use of primary and secondary care services increased with increasing frailty severity. Overall cohort care costs for were highest in mild frailty in all 12 years, followed by moderate and severe, although the proportion of the population with severe frailty can be expected to increase over time. After adjusting for sociodemographic factors, compared to the fit category, individual annual costs doubled in mild frailty, tripled in moderate and quadrupled in severe.
Conclusions: Increasing levels of frailty are associated with an additional burden of individual service use. However, individuals with mild and moderate frailty contribute to higher overall costs. Earlier intervention may have the most potential to reduce service use and costs at population level.
Keywords: frailty; health care costs; older people; primary health care; secondary health care.
© The Author(s) 2024. Published by Oxford University Press on behalf of the British Geriatrics Society.
Conflict of interest statement
HP has received lecture fees or sponsorship from Abbott, Pfizer, HC-UK conferences and UCB pharma outside of the submitted work and is supported by the NIHR Southampton Biomedical Research Centre, Nutrition, and the University of Southampton. S de L has research funding through his University from AstraZeneca, GSK, Moderna, MSD, Sanofi, Seqirus and Takeda. He has been a member of advisory boards for AstraZeneca, GSK, Sanofi and Seqirus, with funding paid to his University. AC is part-funded by the National Institute for Health Research Applied Research Collaboration Yorkshire & Humber, the NIHR Leeds BRC and Health Data Research UK, an initiative funded by UK Research and Innovation Councils, NIHR and the UK devolved administrations and leading medical research charities.
References
-
- Fried LP, Tangen CM, Walston J et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56: M146–57. - PubMed
-
- NHS England . NHS Standard General Medical Services Contract 2017/18, 2018.
-
- Jin HY, Liu X, Xue QL, Chen S, Wu C. The association between frailty and healthcare expenditure among Chinese older adults. J Am Med Dir Assoc 2020; 21: 780–5. - PubMed
